DJIA 17,813.39 1.20 0.01%
NASDAQ 5,116.14 13.34 0.26%
S&P 500 2,088.87 -0.27 -0.01%
market minute promo

Roche Holding Ltd. (ADR) (NASDAQOTH: RHHBY)

33.19 0.30 (0.90%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

RHHBY $33.19 0.90%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $33.38
Previous Close $32.90
Daily Range $33.18 - $33.43
52-Week Range $31.50 - $38.54
Market Cap $186.5B
P/E Ratio 0.00
Dividend (Yield) $0.00 (2.5%)
Volume 587,388
Average Daily Volume 1,215,756
Current FY EPS $1.82





Roche Holding Ltd. (ADR) (RHHBY) Description


News & Commentary

Why Celldex Therapeutics Shares Jumped Today

Positive new data for a promising new treatment for brain cancer could help clear the way to a new standard of care.

Did You Miss These Top Stories in Healthcare?

Last week's most exciting healthcare news: Exelixis nets a win, and Colorado takes aim at health insurers.

6 Stocks That Could Double In 2016

If you have some extra cash and want to take a chance, these six stocks have the potential for excellent returns.

5 Reasons Roche Thinks It Can Outclass the Competition

With five compounds unchallenged in their class, Roche has one of the industry's most exciting late-stage pipelines.

Why Exelixis Shares Declined Today

Financial results trump the FDA approval of a key new drug.

Why Halozyme Therapeutics Inc Is Heading Lower Today

An increase in spending caused results to come up a bit short of expectations, but the long term story appears to be on track.

3 Biotech Stocks to Buy in November

Our Motley Fool contributors think that these 3 biotech stocks are great buys right now.

5 Healthcare Trends to Invest in for the Next 20 Years

Our contributors think that healthcare-focused investors should watch these 5 long-term healthcare trends.

Why Pacific Biosciences of California Jumped Today

The sequencer maker scales the wall of worry created by its competitor.

Did Roche Unleash Biogen's Worst Nightmare?

Roche's once-failed rheumatoid arthritis therapy hit a bullseye in relapsing multiple sclerosis.

See More RHHBY News...

RHHBY's Top Competitors

RHHBY $33.19 (0.90%)
Current stock: RHHBY
JNJ $101.96 (-0.08%)
Current stock: JNJ
NVS $85.95 (-0.52%)
Current stock: NVS
GSK $40.70 (0.77%)
Current stock: GSK